CUPPA is a tissue of origin classifier that uses features derived from whole genome sequencing (WGS; DNA) and/or whole transcriptome sequencing data (WTS; RNA). The Python classifier component of CUPPA is built off the scikit-learn library and is based on multiple logistic regressions chained together. Please see the section Classifier structure for more information.
CUPPA is intended to provide:
- Molecular tumor type prediction to verify histopathological classification
- Support for specific tumor type classification in case of inconclusive histopathological outcome (differential diagnosis)
- Predictions of primary tumor location for Cancer of Unknown Primary (CUP)
- Usage
- Classifier output
- Features
- Classifier structure
- Training set
The latest version of CUPPA can be downloaded from the HMFTools releases page.
The CuppaDataPrep java class can be used to extract the features required for CUPPA. CuppaDataPrep can be run for a single sample or
multiple samples.
The below command will extract the DNA and RNA features for one sample:
java -cp cuppa.jar com.hartwig.hmftools.cup.prep.CuppaDataPrep \
-sample COLO829v003T \
-categories ALL \
-ref_genome_version V37 \
-sample_data_dir /dir/with/all/input/files/ \
-output_dir path/to/output/dir/ \
-ref_alt_sj_sites /path/to/alt_sj.selected_loci.tsv.gzThis will produce a TSV file with the following format:
Source Category Key Value
DNA snv96 C>A_ACA 131
DNA gen_pos 1_500000 2
... ... ... ...
In the single sample example, we have all input files in the path provided to -sample_data_dir. However, for multiple samples, the input
files are likely located in separate dirs.
We can instead provide input paths to -purple_dir, -linx_dir, -virus_dir, and -isofox_dir
using with wildcards (*) which are converted to sample ids as specified in the -sample_id_file. NOTE: Paths containing wildcards must
be surrounded by double quotes (")!
The below command will extract the DNA and RNA features for multiple samples:
java -cp cuppa.jar com.hartwig.hmftools.cup.prep.CuppaDataPrep \
-sample_id_file /path/to/sample_ids.tsv \
-categories ALL \
-ref_genome_version V37 \
-purple_dir "/data/datasets/*/purple/" \
-linx_dir "/data/datasets/*/linx/" \
-virus_dir "/data/datasets/*/virus_interpreter/" \
-isofox_dir "/data/rna/*/" \
-output_dir /path/to/output/dir/ \
-ref_alt_sj_sites /path/to/alt_sj.selected_loci.tsv.gz \
-write_by_category \
-threads 8Because -write_by_category was specified, this will produce multi TSV files:
cuppa_data.cohort.snv.tsv.gzcuppa_data.cohort.sv.tsv.gzcuppa_data.cohort.driver.tsv.gzcuppa_data.cohort.sample_trait.tsv.gzcuppa_data.cohort.alt_sj.tsv.gzcuppa_data.cohort.gene_exp.tsv.gz
Using -write_by_category is handy to prevent the output files from becoming too big (i.e. when running CuppaDataPrep on thousands of
samples). Alternatively, if -write_by_category is not specified, one output file is produced:
cuppa_data.cohort.tsv.gz
These 'cohort' TSV files have the following format:
Source Category Key SAMPLE_1 SAMPLE_2
DNA snv96 C>A_ACA 131 5
DNA gen_pos 1_500000 2 2
... ... ... ... ...
Below is a description of the required input files:
| Tool | Filename suffix | File details |
|---|---|---|
| PURPLE | .purple.somatic.vcf.gz | SNVs; used for the GEN_POS and SNV96 features |
| PURPLE | .purple.sv.vcf.gz | Structural variants |
| PURPLE | .purple.purity.tsv | Sample sex and WGD presence (amongst other data) |
| PURPLE | .purple.qc | WGS quality control stats |
| LINX | .linx.clusters.tsv | Structural variant clusters |
| LINX | .linx.driver.catalog.tsv | Driver mutations |
| LINX | .linx.fusion.tsv | Gene fusions |
| Virus Interpreter | .virus.annotated.tsv | Viral sequence insertions |
Below are all arguments that can be passed to CuppaDataPrep. Superscript numbers mark conditionally required arguments.
| Argument | Example | Description |
|---|---|---|
-sample |
COLO829v003T | [Required 1] Sample name |
-sample_id_file |
sample_ids.tsv | [Required 1] One column text file with "SampleId" as the header, and where each row is a sample name |
-sample_data_dir |
[Required 2] Directory containing all input files | |
-purple_dir |
"/data/datasets/*/purple/" | [Required 2] Directory containing the PURPLE files |
-linx_dir |
"/data/datasets/*/linx/" | [Required 2] Directory containing the LINX files |
-virus_dir |
"/data/datasets/*/virus_interpreter/" | [Required 2] Directory containing the VirusInterpreter files |
-isofox_dir |
"/data/rna/*/" | [Required 2] Directory containing the ISOFOX files |
-ref_alt_sj_sites |
alt_sj.selected_loci.tsv.gz | [Required 3] TSV file containing the required alternative splice junctions. Required columns: GeneId, Chromosome, PosStart, PosEnd |
-categories |
DNA | [Required] One of: ALL, DNA, RNA; or one/many of: SNV, SV, DRIVER, SAMPLE_TRAIT, GENE_EXP, ALT_SJ |
-output_dir |
[Required] Directory to write the output files | |
-ref_genome_version |
V37 | Valid values: V37 (default), V38 |
-threads |
8 | Number of threads to use. Each thread processes one sample at a time |
-write_by_category |
Flag. Split output of CuppaDataPrep over multiple files |
|
-progress_interval |
100 | Print progress per this number of samples in multi-sample mode |
-log_level |
DEBUG | Set log level to one of: ERROR, WARN, INFO, DEBUG or TRACE |
-log_debug |
Flag. Set log level to DEBUG |
Conditional requirements:
- Either
sampleorsample_id_fileis required - One or many of
-sample_data_dir,-purple_dir,-linx_dir,-virus_dir, or-isofox_dirare provided such that the combination of directories covers all input files. Wildcards (*) are replaced with sample names -ref_alt_sj_sitesis required when running in RNA mode (i.e.-categoriesis RNA or ALL).alt_sj.selected_loci.tsv.gzfiles for hg37 and hg38 can be downloaded from the HMFTools-Resources Google cloud bucket
The core classification component of CUPPA is a python package (pycuppa). You may skip to step 3 if you have Python correctly set up.
However, it is recommended to install Python via pyenv (step 1 and 2). This ensures that the correct Python version is installed, as well
as ensuring no dependency collisions with the system pre-installed Python.
- Install
pyenv(for details see: https://github.com/pyenv/pyenv):
## Download and run the auto-install script
curl https://pyenv.run | bash
## Set up the shell environment
echo '
export PYENV_ROOT="$HOME/.pyenv"
command -v pyenv > /dev/null || export PATH="$PYENV_ROOT/bin:$PATH"
eval "$(pyenv init -)"
' >> ~/.bashrc ## On MacOS, change this to ~/.zshrc- Install Python and create a virtual environment:
## `pycuppa` requires Python 3.9 or higher
pyenv install 3.9.4
## Create a virtual environment with Python 3.9.4 as the base
pyenv virtualenv 3.9.4 pycuppa_venv
## Activate the virtual environment
pyenv activate pycuppa_venv3a. Install pycuppa from the hmftools repo:
## Clone the hmftools repository
git clone https://github.com/hartwigmedical/hmftools/
## Upgrade python package manager
pip install --upgrade pip
## Install `pycuppa`. This will also install required python packages
pip install hmftools/cuppa/src/main/python/pycuppa3b. Alternatively, install pycuppa from a CUPPA jar file (see releases for available versions):
## Download a cuppa jar. Replace the URL with the desired version
wget https://github.com/hartwigmedical/hmftools/releases/download/cuppa-v2.2.1/cuppa_v2.2.1.jar
## Extract the contents of the jar. Jars are just zip files!
mkdir cuppa_jar/
tar -xvzf cuppa_v2.2.1.jar -C cuppa_jar/
## Upgrade python package manager
pip install --upgrade pip
## Install the `pycuppa` python package embedded in the jar
pip install cuppa_jar/pycuppa/Pre-trained classifiers (cuppa_classifier.pickle.gz files) for hg37 and hg38 can be downloaded from the
HMFTools-Resources Google cloud bucket.
To predict on a single sample, the below example commands can be used. This produces the outputs as specified in section: Classifier output.
## Activate the previously created virtual environment
pyenv activate pycuppa_venv
## Call the module `pycuppa/cuppa/predict.py`
python -m cuppa.predict \
--sample_id TUMOR_SAMPLE \
--classifier_path /path/to/cuppa_classifier.pickle.gz \
--features_path /path/to/features/ \
--output_dir /path/to/output/dir/To train a new model, the following example command can be used:
## Activate the previously created virtual environment
pyenv activate pycuppa_venv
## Call the module `pycuppa/cuppa/train.py`
python -m cuppa.train \
--features_path /path/to/features/ \
--metadata_path /path/to/metadata/ \
--output_dir /path/to/output/dir/ \
--n_jobs 5 \
--log_to_fileThe below table lists all possible arguments for training and/or predicting.
| Argument | Task | Description |
|---|---|---|
--features_path |
Both | [Required] Single sample mode: Path to the *.cuppa_data.tsv.gz file. Multi-sample mode: Path to the directory with the cuppa_data.cohort.*.tsv.gz files |
--output_dir |
Both | [Required] Output directory |
--classifier_path |
Predict | [Required] Path to the pickle file containing a CuppaClassifier python object |
--sample_id |
Predict | [Required in single sample mode] Adds sample_id within output files and to the output filenames |
--metadata_path |
Train | [Required] Path to the metadata file with cancer type labels per sample |
--cv_predictions_path |
Predict | Path to a CuppaPrediction tsv file containing the cross-validation predictions. Samples found in this file will have their predictions returned from this file instead of being computed |
--compress_tsv_files |
Predict | Compress tsv files with gzip? (will add .gz to the file extension) |
--excl_classes |
Train | Comma separated list of cancer subtypes to exclude from training. E.g. 'Breast' or 'Breast,Lung'. Default: '_Other,_Unknown' |
--min_samples_with_rna |
Train | Minimum number of samples with RNA in each cancer subtype. If the cancer subtype has fewer samples with RNA than this value, the cancer subtype will be excluded from training. Default: 5 |
--fusion_overrides_path |
Train | Path to the fusion overrides tsv file. See section FusionProbOverrider for how this file should be formatted |
--cv_folds |
Train | Number of cross-validation folds. Default: 10 |
--skip_cv |
Train | Skip cross-validation? |
--no_cache_training |
Train | Don't cache models during cross-validation and training of final model? |
--n_jobs |
Train | Number of threads to use for cross-validation. If -1, all threads are used. Default = 1 |
--log_to_file |
Train | Output logs to a file? |
--log_path |
Train | Path to log file. Default: ${output_dir}/run.log |
This file specifies the cancer type labels for each sample. Internally, CancerSubtype is used as the label for each
sample, and corresponds to the cancer types that CUPPA classifies.
RnaReadLength together with CancerSubtype is used to create
stratified
cross-validation splits so that RnaReadLength and CancerSubtype is evenly distributed across the cross-validation
folds. RnaReadLength is also used when the min_samples_with_rna argument is specified (see above table).
SampleId CancerType CancerSubtype RnaReadLength
sample_1 Prostate Prostate 151
sample_2 Skin Skin: Melanoma 0
... ... ... ...
For more details about this file, see section: FusionProbOverrider.
feat_prefix feat_basename target_class
event.fusion. CBFB_MYH11 Myeloid: Acute myeloid leukemia
event.fusion. CTNNB1_PLAG1 Head and neck: Salivary gland
event.fusion. FUS_DDIT3 Bone/Soft tissue: Liposarcoma
... ... ...
Training of CUPPA and making predictions can be done interactively in Python. Please refer to these jupyter notebooks for example code at doc/notebooks/. This below links:
- predict_example.ipynb: view on nbviewer.org
- train_example.ipynb: view on nbviewer.org
For each sample CUPPA outputs a visualization of the predictions (PNG file), as well as the raw visualization data as a TSV file. Please see later sections for more info on the features and classifiers shown in the visualization.
The CUPPA visualization is split into 4 panels. The first panel shows the probabilities for each cancer subtype (columns) for each classifier (rows). The grey tabs indicate cancer type groupings based on molecular/histological supertypes (e.g. Lung cancer) but also by organ type (Bone/Soft tissue cancers). Group probabilities are shown for the COMBINED, DNA_COMBINED and RNA_COMBINED classifiers, where these probabilities are simply the sum of probabilities within the cancer type grouping and classifier (merged cells).
This panel shows the presence of certain mutational signatures relative to their presence in each cancer type in the training set. Each heatmap cell shows the where a given sample lies in the cancer type cohort distribution for a particular signature (quantile).
NOTE: CUPPA does not use signatures as features internally. These are only displayed for informational purposes to confirm or reject CUPPA's predictions, such as in the following scenario:
- A pathologist determines that a tumor is a breast cancer
- CUPPA predicts the tumor to be a lung cancer
- This tumor has over 10,000 SBS4 (smoking) mutations, which falls within the typical range for lung cancers
- This tumor is therefore more likely to be a lung cancer
This panel shows which EVENT features (driver mutations, fusions, viral insertions, and various other features) were most important for the resulting prediction (from the EVENT classifier). Each heatmap cell shows an odds ratio which are calculated from SHAP values as follows:
shap_value = coef * (x – X_mean) ## SHAP values are in log(odds) space
odds_ratio = e ** shap_value ## Exponentiate by e (=2.718) to get to odds space
Odds ratios impacts probabilities as follows:
- Odds ratio >1: increases the eventual probability for a given cancer type
- Odds ratio <1: decreases the eventual probability for a given cancer type
- Odds ratio == 1: no effect on probabilities
Odds ratios can be interpreted as follows. The sample in the example visualization has a BRAF mutation which has the following odds ratios:
- Breast: Triple negative = 0.6
- Lung: Non-small cell: LUAD = 5.4
- Skin: Melanoma = 48
This means that this sample is:
- 8.9x more likely to be 'Skin: Melanoma' than 'Lung: Non-small cell: LUAD' (48 / 5.4)
- 80x more likely to be 'Skin: Melanoma' than 'Breast: Triple negative' (48 / 0.6)
For each cancer type, the number of training samples, as well recall and precision (as determined by cross-validation) are shown to give an idea about how reliably each cancer type can be predicted.
- Number of training samples: Cancer types with more training samples are usually more reliably predicted
- Recall: A recall of e.g. 0.95 for prostate cancer means that CUPPA expects to miss 5% of prostate cancer cases
- Precision: A precision of e.g. 0.95 for prostate cancer means that of 100 samples CUPPA predicts as prostate cancer, 5% of those predictions are wrong
The visualization data TSV is a long form table. The first and last few rows of the table are shown below.
sample_id data_type clf_group clf_name feat_name feat_value cancer_type data_value rank rank_group
0 SAMPLE_X prob combined combined NaN NaN Anogenital 0.000218 6 0
1 SAMPLE_X prob combined combined NaN NaN Bone/Soft tissue: Cartilaginous neoplasm NaN 34 0
2 SAMPLE_X prob combined combined NaN NaN Bone/Soft tissue: GIST 0.000218 7 0
3 SAMPLE_X prob combined combined NaN NaN Bone/Soft tissue: Leiomyosarcoma 0.000218 8 0
4 SAMPLE_X prob combined combined NaN NaN Bone/Soft tissue: Liposarcoma 0.000218 9 0
... ... ... ... ... ... ... ... ... ...
635 SAMPLE_X feat_contrib dna event sv.TELOMERIC_SGL 1.0 Prostate 1.000000 30 28
636 SAMPLE_X feat_contrib dna event sv.TELOMERIC_SGL 1.0 Skin: Melanoma 1.306432 4 28
637 SAMPLE_X feat_contrib dna event sv.TELOMERIC_SGL 1.0 Skin: Other 1.000000 31 28
638 SAMPLE_X feat_contrib dna event sv.TELOMERIC_SGL 1.0 Thyroid gland 1.000000 32 28
639 SAMPLE_X feat_contrib dna event sv.TELOMERIC_SGL 1.0 Urothelial tract 1.000000 33 28
Below is a description of the columns:
| Column name | Column description | Data type | Valid values / Value description |
|---|---|---|---|
sample_id |
Sample ID | String | |
data_type |
Data type | String | prob: probabilities feat_contrib: feature contributions sig_quantiles: mutational signature quantiles cv_performance: training set cross-validation performance metrics |
clf_group |
Classifier group | String | combined, dna, rna |
clf_name |
Classifier name | String | combined, dna_combined, gen_pos, snv96, event, rna_combined, gene_exp, alt_sj |
feat_name |
EVENT feature name | String | e.g. tmb.snv_count. Only when data_type is "feat_contrib" or "cv_performance", otherwise empty |
feat_value |
EVENT feature value | Float | e.g. 20000.0. Only when data_type is "feat_contrib", otherwise empty |
data_value |
Value of data_type |
Float | e.g. if data_type is "prob", data_value represents probabilities |
rank |
Rank of data_value |
Integer | |
rank_group |
Grouping of [data_type, clf_name, feat_name] by which data_value is ranked |
Integer |
The features used by CUPPA are derived from DNA and RNA sequencing. These features are provided to CUPPA as a single dataframe containing the features (columns) for each sample (rows).
| Source | Feature type | Feature description | No. of features |
|---|---|---|---|
| DNA | GEN_POS | No. of SNVs per 500kb bin across the genome | 6,101 |
| DNA | SNV96 | No. of SNVs per 96-trinucleotide context | 96 |
| DNA | EVENT | Mutations in genes (driver likelihood) | 620 |
| DNA | EVENT | Gene fusions (presence) | 143 |
| DNA | EVENT | Viral insertions (presence) of HBV, HPV, HSV or MCPyV | 4 |
| DNA | EVENT | Structural variant (SV) types | 6 |
| DNA | EVENT | Tumor mutational burden (TMB; no. of SNVs and indels) | 2 |
| DNA | EVENT | Whole genome duplication (presence) | 1 |
| DNA | EVENT | Sample sex (male/female) | 1 |
| RNA | GENE_EXP | log(transcripts per million + 1) for each gene | 37,985 |
| RNA | ALT_SJ | log(number of reads + 1) for each alternative splice junction | 236,328 |
The genomic position of somatic SNVs, also known as regional mutational density (RMD). These have been previously associated with tissue type-specific chromatin states [Lehner et al. 2012, Nature] and were shown to have strong predictive power for tissue of origin [Jiao et al. 2020, NatComm].
For CUPPA, we count the number of SNVs in each 500kb bin across the genome for each sample. Chromosome Y is excluded to avoid sex-related effects. We also exclude the mutations characteristic of AID-APOBEC hypermutation (T[C>T]N and T[C>G]N) as we observe them to have a distinct genomic position profile which does not generally match the cancer specific profile (predominantly affecting Lung, Breast and Urothelial cancers).
The SNV counts in the 96-trinucleotide contexts reflects specific mutagenic effects such as UV radiation, smoking, and background mutational processes. While these trinucleotide contexts are often used for the COSMIC single base substitution (SBS) signatures, CUPPA does not use the COSMIC signatures directly. However, the SNV96 sub-classifier is designed to capture the obvious similarities that can also be observed via signatures.
The EVENT group of features contains various driver and passenger mutational features that are specific to certain cancer types.
Driver (or driver like) features used include all driver point mutation, high amplification, homozygous deletion and homozygous disruptions in the driver catalog. Homozygous deletions, disruptions and mutations drivers are considered together, but amplifications are treated as a separate feature as some oncogenes tend to be amplified in specific cancer types and mutated in others (notable examples are KRAS, EGFR, SPOP & FOXA1).
Indels in repeat contexts of 6 or fewer bases in 3 lineage defining genes: ALB (highly specific to Liver cancer) and SFTPB & SLC34A2 (highly specific to Lung cancer) are also treated as additional features (note though that they are ignored for MSI samples). A set of Lung cancer specific EGFR hotspots (including T790M, L858R and exon 19 and 20 inframe deletions) are also treated as a single feature.
Known pathogenic fusion pairs, immunoglobulin (IG) rearrangement pairs and exon deletions/duplications configured in the HMF fusion knowledge base are all considered as features, as are fusions with highly promiscuous exons such as ALK exon 20-21.
Some viruses can integrate their DNA into the host genome and are thus carcinogenic [Zapatka et al. 2020, NatGen]. Some of these are also cancer type specific and have been included as features, including human papillomavirus (HPV; cervical and head & neck cancers), merkel cell polyomavirus (MCPyV; skin carcinomas), hepatitis B virus (HBV; liver cancer), and herpes simplex virus (HSV; various cancer types).
CUPPA uses various cancer type specific SV types as features:
- LINE: Long interspersed nuclear elements. Often found in esophageal, head & neck, and colorectal cancers [Roderiguez-Martin et al. 2020, NatGen]
- SIMPLE_DEL_20KB_1MB: Simple structural deletions, 10kb to 1Mb in size
- SIMPLE_DUP_32B_200B: Simple structural duplications, 30bp to 200bp in size
- SIMPLE_DUP_100KB_5MB: Simple structural duplications, 100kb to 5Mb in size
- MAX_COMPLEX_SIZE: Size of the largest complex structural event (number of chained SVs), a proxy measure for the presence of chromothripsis
- TELOMERIC_SGL: Telomeric single breakends. Associated with telomere lengthening in Leiomyosarcomas [Chudasama et al. 2018, NatComm]
Certain cancer types have an extremely high number of mutations, such as skin and lung cancers (due to UV radiation and smoking respectively), while other have very few mutations, such as medulloblastomas and pilocytic astrocytomas (due to typically being pediatric cancers). CUPPA thus uses the total number of SNVs and indels as features.
The rate of WGD varies by cancer type [Priestley et al. 2019, Nature].
Cancers of the reproductive organs are exclusively male (e.g. prostate cancer) or female (e.g. ovarian, uterine, cervical cancers). Sex (male/female) is determined using the copy number of the sex chromosomes and is used as a feature in CUPPA.
Genes are differentially expressed across tissue types and can thus be used for CUP classification. Normalized
transcript counts for each gene in log(transcripts per million + 1) are used as input for CUPPA.
A novel splice junction is defined in this context as any splice junction that is not annotated in ENSEMBL. A set of recurring novel splice junctions sites were identified within each cancer cohort – i.e. those with 3 or more fragments supporting a novel site in 2 or more samples. Intronic splice sites were excluded from the analysis. A reference file was then formed by calculating the average fragment count per cancer cohort at each of these novel sites.
This section provides details on each component of the CUPPA classifier. CamelCase headings refer to the class name of the respective component.
CUPPA is composed of 2 main layers of multinomial logistic regressions, and a final post-processing layer:
- Sub-classifier layer: Each of the 5 feature types (GEN_POS, SNV96, EVENT, GENE_EXP, ALT_SJ) is passed as input to a sub-classifier for the corresponding feature type. Each sub-classifier performs some feature transformations, after which a logistic regression weighs the importance of each transformed feature.
- Meta-classifier layer: This layer uses 2 logistic regressions to weigh the importance of the DNA and RNA sub-classifiers, followed by some post-processing steps.
- Combined layer: Combines the probabilities from the meta-classifiers by multiplying them together.
The logistic regressions in all CUPPA classifiers share the following arguments:
multi_class="multinomial": A multinomial regression is used as our task is to classify multiple cancer types ('classes')solver="saga": The SAGA (Stochastic Average Gradient Accelerated) solver is used as it is the only one that supports multinomial LASSO logistic regression in scikit-learn. SAGA is an optimized variant of stochastic gradient descent (SGD).class_weight="balanced": Some cancer types in the training set have more samples than others. The "balanced" argument forces the logistic regression to optimize equally every cancer type cohort by weighing cohorts by the inverse of their sample size:cancer_type_weight = n_samples_total x (1 / n_samples_in_cancer_type).random_state=0: Set the random seed so that re-running the training produces the same model.
The GEN_POS, SNV96, and EVENT logistic regressions use the following non-default arguments:
penalty="l1": LASSO (aka L1) regularization is used to remove irrelevant features during training by setting their weights to 0max_iter=1000: Number of gradient descent iterations
The GENE_EXP and ALT_SJ logistic regressions use the following non-default arguments:
penalty="l1": See abovemax_iter=10000: See above
The DNA_COMBINED and RNA_COMBINED logistic regressions use the following non-default arguments:
penalty='l2': Ridge regularization reduces the weights of less relevant features. Ridge is used instead of LASSO here as all output probabilities from sub-classifiers are relevant albeit to different extents.C=4: Increased C from 1 (default) to 4 to reduce the strength of ridge regularizationmax_iter=1000: See above
Below are details of the components responsible for transforming the features before being fed into the logistic regressions, and post-processing of the probabilities outputted by the logistic regressions.
For the GEN_POS classifier, consensus GEN_POS profiles are calculated per cancer type at training time. At prediction time, the cosine similarity of a sample's profile to each per cancer type profile is then calculated.
The consensus profile is the sum (agg_func="sum") of each 500k bin in samples of a particular cancer
type. Sum is used instead of mean as we want samples with low TMB (which have a noisier GEN_POS profile) to contribute
less to the consensus profile.
Conversely, we want hypermutator samples to contribute less to the consensus profile as to not dominate the profile.
Thus, if a sample has more than 10,000 SNVs (count_ceiling=10000), the GEN_POS profile of that sample will be scaled
down such that the TMB sums to 10,000.
For the GENE_EXP and ALT_SJ classifiers, no count_ceiling is used and the mean (agg_func="mean") to generate the
consensus profiles. This is because the (log transformed) GENE_EXP and ALT_SJ features are not skewed by outliers.
For cancer types cohorts with few samples, the addition of one hypothetical new sample would result in a drastic change in the consensus profile. Small cancer type cohorts therefore tend to have highly variable consensus GEN_POS profiles.
To counteract this, we add a background 'noise' GEN_POS profile totalling 500 mutations (noise_counts=500) to every
sample before generating the consensus profiles. The noise GEN_POS profile is the median of the per-cancer type
profiles as generated by ProfileSimilarityTransformer, and is calculated at training time.
The GEN_POS consensus profiles of small cohorts will therefore tend towards the noise profile, thereby diminishing the importance of GEN_POS for these cohorts (and increasing the relative importance of other feature types).
A major problem with cosine similarities is that they tend towards 1.0 with higher the numbers of dimensions (i.e. features). With 6101 GEN_POS bins, the (sorted) cosine similarities are often squished towards 1.0 like this:
cos_sims = [0.95, 0.92, 0.87, 0.86, 0.75, …]
However, we want larger differences between consecutive cosine similarities as this improves the performance of the downstream logistic regression. To achieve this, we perform the following computations:
exponent = 5
max_value = max(cos_sims) ## 0.95
scale_factors = cos_sims - max_value + 1 ## [1.00, 0.97, 0.92, 0.91, 0.80, ...]
scale_factors = scale_factors ** exponent ## [1.00, 0.86, 0.67, 0.62, 0.32, ...]
cos_sims_scaled = scale_factors * cos_sims ## [0.95, 0.79, 0.57, 0.54, 0.23, ...]Larger exponent values push the bottom values closer to zero. exponent values were empirically chosen based on the
one that yield the best performance:
- GEN_POS:
exponent=5 - GENE_EXP:
exponent=5 - ALT_SJ:
exponent=2
Log transformation is performed to eliminate the effect of outliers (e.g. samples with exceptional high number of SNVs). The "+1" pseudocount is to prevent calculating log(0) which is undefined.
Max scaling is performed to scale (non-negative) features to range from 0 to 1. This is because the downstream logistic regression expects features to be (roughly) in the same scale and range. This is performed for the SV and TMB features as well as for the GENE_EXP and ALT_SJ features.
The chi2 test is used to as a preliminary feature selection step remove irrelevant features (applies to drivers mutations, gene fusions, viral integrations, sex, and whole genome duplication). This test quantifies how much each feature varies across every cancer type in the training set compared to an expected (background) value for that feature. The below pseudo-code describes the feature selection procedure:
## Inputs
X ## Feature values per sample. Matrix of shape [n_samples, n_features]
y ## Cancer type labels per sample. Array of length n_samples
## Sum of the values of each feature across all samples. Array of length n_features
feature_counts = X.sum(axis="columns")
## Proportions of each cancer type in `y`. Array of length n_cancer_types
cancer_type_freq = count_samples_per_cancer_type(y) / len(y)
## Calculate expected counts per feature per cancer type. Matrix of shape [n_cancer_types, n_features]
expected_counts = dot_product(cancer_type_freq, feature_counts)
## Calculate observed feature counts per cancer type
X_split = split_rows_by_cancer_type(X)
observed_counts = [X_i.sum(axis="columns") for X_i in X_split] ## List of length n_cancer_types
observed_counts = as_matrix(observed_counts) ## Matrix of shape [n_cancer_types, n_features]
## Calculate chi2 statistic. Array of length n_features
chi2_stat = (observed_counts – expected_counts)**2
## Calculate pvalue = area under the right-hand tail of the chi2 probability density function
## Array of length n_features
pvalue = chi2_pdf(chi2_stat)
## Calculate false discovery rate and select features
## Array of length n_features
fdr = benjamini_hochberg(pvalue)
selected_feature_names = X.columns[fdr<0.001]For the GENE_EXP and ALT_SJ classifiers, MaxScaledChi2FeatureSelector combines the MaxScaler and Chi2FeatureSelector steps.
Samples with no RNA data will bypass the RNA classifiers (GENE_EXP, ALT_SJ, RNA_COMBINED).
This component combines the probabilities of the DNA_COMBINED and RNA_COMBINED meta-classifiers by multiplying them together.
It is however possible that the probability for a cancer type is 0.99 for DNA_COMBINED but 0.00 for RNA_COMBINED, which
when multiplied together equals 0.00. To avoid this issue, all probabilities <0.01 are set to 0.01 (prob_floor=0.01)
prior to multiplication. After multiplying the probabilities, they are normalized to sum to 1.
Probability calibration is performed to ensure that a probability of 0.8 means that: of 100 samples predicted as e.g. breast cancer, 80 of these are actually breast cancer. Logistic regressions generally output under-confident probabilities, e.g. a probability of 0.75 in practice means a probability of 0.85.
Calibration can be performed using isotonic regressions, but these require lots of samples from target cancer type to train. "Rolling average calibration" is an adaptation of isotonic regression that allows training on cancer type cohorts with too few samples (<10; e.g. acute myeloid leukemia, AML) and is performed as follows (using AML as an example):
Given:
x: float array, probability of AML for each sampley: boolean array, 1 = AML and 0 = not AML
Do:
- Order both arrays by the probabilities (i.e.
x) - Slide a window along
yand take the mean of the values in the window at each step. This produces more granularyvalues (boolean array converted to float array). - Fit the isotonic regression on
xandy - At prediction time, calibrated probabilities are normalized to sum to 1
Calibration also increases the number of high confidence probabilities (>0.8, the threshold for a diagnosis), allowing for more CUP patients to be diagnosed.
Certain gene fusions are highly characteristic of certain cancer types, e.g. RUNX1-RUNX1T1 for acute myeloid leukemia (AML), but were not prevalent enough in the training set (i.e. too few training samples) to be picked up as dominant feature for that cancer type. If a RUNX1-RUNX1T1 fusion were found in a sample for example, we would force a high probability of AML. This 'fusion override' for this example sample is done using the below pseudo-code:
## Raw probabilities for sample with RUNX1-RUNX1T1 fusion
## Acute myeloid leukemia (AML) is often misclassified as myeloproliferative neoplasm (MPN)
classes = ["AML", "MPN", "Liver", "Prostate", ...]
probs = [0.26, 0.31, 0.02, 0.01, ...]
## Make 'mask' array
## 1.00 for target cancer type(s). Can be multiple cancer types
## 0.01 for other cancer types. Value specified with the `mask_base_value` argument
mask = [1.00, 0.01, 0.01, 0.01, ...]
## Apply mask
probs = probs * mask ## [0.26, 0.03, 0.00, 0.00, ...]
## Normalize probabilities to sum to 1
probs = probs / sum(probs)In total, there are 64 pathognomic fusion-cancer type mappings for which we apply a fusion override. These mappings are
provided to the overrides argument of FusionProbFilter as a dataframe in the format shown in section
Fusion overrides file
It is possible for e.g. a genetically female sample to have a non-zero probability of Prostate, since the logistic regressions do not treat female and male cancer types differently. We therefore force the probability of male cancer types to be 0 in female cancer types, and vice versa.
Keywords for male and female cancer types are specified to the keywords_male_classes and keywords_female_classes
SexProbFilter arguments. SexProbFilter will be applied to any cancer types containing these keywords (case insensitive).
By default, the keywords are:
_DEFAULT_KEYWORDS_MALE_CLASSES = [
"prostate",
"penis","penile",
"testis","testicular"
]
_DEFAULT_KEYWORDS_FEMALE_CLASSES = [
"ovary","fallopian","ovarian",
"uterus","uterine","endometrium","endometrial",
"cervix","cervical"
] ## We do not override "breast" as breast cancers are also found in male patientsAfter overriding the probabilities, they are normalized to sum to 1.
Samples were included in the training set if they passed the following criteria:
- From the
puritySQL table:- qcStatus == "PASS"
- purity > 0.195
- fitMethod != "NO_TUMOR"
- From LAMA (patient consent database):
- intUse == TRUE
- storeData == TRUE
As multiple samples can originate from the same patient, we de-duplicate samples by prioritizing samples with 151bp read length RNA data, followed by highest tumor purity.
The below table summarizes the cancer subtype mappings based on clinical annotations in the HMF database as well as in the PCAWG metadata. The definitions are specified in following format:
primaryTumorLocation/pcawgCancerType:primaryTumorSublocation- (
primaryTumorType:primaryTumorSubType) - <
histology>
Additionally, two special operators are used:
[ ]: list/groupingnot: excludes the proceeding cancer types
| Cancer subtype | Rules | Samples | Samples w/ RNA |
|---|---|---|---|
| Anogenital | Anus, Penis, Vulva, Vagina, Uterus: Cervix, Cervix-AdenoCA, Cervix-SCC | 128 | 46 |
| Bone/Soft tissue: Cartilaginous neoplasm | Bone-Cart | 9 | 0 |
| Bone/Soft tissue: GIST | Bone/Soft tissue (Gastrointestinal stromal tumor) | 66 | 27 |
| Bone/Soft tissue: Leiomyosarcoma | Bone/Soft tissue (Leiomyosarcoma), SoftTissue-Leiomyo | 80 | 19 |
| Bone/Soft tissue: Liposarcoma | Bone/Soft tissue (Liposarcoma), SoftTissue-Liposarc | 59 | 5 |
| Bone/Soft tissue: Osteosarcoma | Bone/Soft tissue (Osteosarcoma), Bone-Osteosarc | 47 | 0 |
| Bone/Soft tissue: Undiff. sarcoma | Bone/Soft tissue (Undifferentiated sarcoma), Bone/Soft tissue (Fibrous histiocytoma) | 37 | 6 |
| Bone/Soft tissue: Other | Bone/Soft tissue ([not Skin, unspecified]), Bone-Epith, Bone-Osteoblast | 157 | 49 |
| Breast: Other | Breast (unspecified: not Triple negative), [Breast-AdenoCA, Breast-DCIS, Breast-LobularCA] | 908 | 412 |
| Breast: Triple negative | Breast (unspecified: Triple negative), [Breast-AdenoCA, Breast-DCIS, Breast-LobularCA] | 183 | 59 |
| CNS: Glioma | Nervous system (Glioma), CNS-GBM, CNS-Oligo | 159 | 63 |
| CNS: Medulloblastoma | Nervous system (unspecified: Medulloblastoma), CNS-Medullo | 138 | 0 |
| CNS: Pilocytic astrocytoma | CNS-PiloAstro | 58 | 0 |
| Colorectum/Small intestine/Appendix | [Colorectum, Appendix, Small intestine] (not Neuroendocrine tumor), ColoRect-AdenoCA | 837 | 336 |
| Esophagus/Stomach | [Esophagus, Stomach, Gastroesophageal] (not Neuroendocrine tumor), Stomach-AdenoCA, Eso-AdenoCA | 349 | 130 |
| Gynecologic: Endometrium | Uterus: Endometrium (not Neuroendocrine tumor) | 85 | 24 |
| Gynecologic: Ovary/Fallopian tube | [Ovary, Fallopian tube, Ovary-AdenoCA] (not Neuroendocrine tumor) | 320 | 112 |
| Head and neck: Adenoid cystic | (Carcinoma: Adenoid cystic carcinoma) | 10 | 5 |
| Head and neck: Salivary gland | Salivary gland, Trachea, Head and neck: [Salivary gland, Parotid gland, Sublingual gland] | 26 | 15 |
| Head and neck: Other | Head and neck: unspecified | 101 | 28 |
| HPB: Bile duct/Gallbladder | Bile duct, Hepatobiliary system, Gallbladder, Biliary-AdenoCA | 131 | 78 |
| HPB: Liver | Liver, Liver-HCC | 341 | 35 |
| HPB: Pancreas | Pancreas (not Neuroendocrine tumor), Panc-AdenoCA | 372 | 65 |
| Kidney: Chromophobe | Kidney (unspecified: Chromophobe renal cell carcinoma), Kidney-ChRCC | 44 | 0 |
| Kidney: Other | Kidney (unspecified), Kidney-RCC | 277 | 76 |
| Lung: Non-small cell: LUAD | Lung [(Carcinoma: Adenocarcinoma), ], Lung-AdenoCA | 254 | 107 |
| Lung: Non-small cell: LUSC | Lung [(Carcinoma: Squamous cell carcinoma), ], Lung-SCC | 78 | 12 |
| Lung: Small cell | Lung (Carcinoma: [Small cell carcinoma, Small cell carcinoma combined type]) | 56 | 35 |
| Lymphoid tissue | Lymphoid tissue, Lymph-BNHL, Lymph-CLL | 216 | 20 |
| Mesothelium | Mesothelium | 77 | 23 |
| Myeloid: Acute myeloid leukemia | Myeloid-AML | 12 | 0 |
| Myeloid: Myeloproliferative neoplasm | Myeloid-MPN | 18 | 0 |
| NET: Colorectum/Small intestine | [Colorectum, Small intestine] (Neuroendocrine tumor) | 56 | 34 |
| NET: Lung | Lung (Neuroendocrine tumor) | 46 | 5 |
| NET: Pancreas | Pancreas (Neuroendocrine tumor), Panc-Endocrine | 118 | 21 |
| Prostate | Prostate (not Neuroendocrine tumor), Prost-AdenoCA | 607 | 161 |
| Skin: Melanoma | Skin (Melanoma), Skin-Melanoma | 408 | 133 |
| Skin: Other | Skin (unspecified), Bone/Soft tissue: Skin | 49 | 19 |
| Thyroid gland | Thyroid gland, Thy-AdenoCA | 71 | 16 |
| Urothelial tract | Urothelial tract, Bladder-TCC | 241 | 45 |
Grouping of subtypes are made based on molecular/histological supertypes (e.g. Lung cancer) but also by organ type (Bone/Soft tissue cancers) for the visualization of CUPPA.
The cancer subtype group is simply the prefix before the first colon (":"). For example, "Bone/Soft tissue: GIST" maps to the "Bone/Soft tissue" group. Subtypes with no prefix (i.e. no ":") belong to their own standalone group. For example, "Anogenital" maps to the "Anogenital" supertype.
CUPPA internally predicts subtype probabilities. Group probabilities are simply the sum of the subtype probabilities of a particular group.
The training data for CUPPA includes: i) a dataframe containing the features (columns) per sample (rows), and ii) an array of known cancer type labels for each sample. All samples from the training set are used to train the final CUPPA classifier.
10-fold cross-validation was used to assess the performance of CUPPA. Here, the training data was split into 10 parts, training was performed on 90% of samples, and tested on the remaining 10% of samples. This was repeated for the 10 different 'folds', each yielding cancer type probabilities for a different 10% subset of samples, and ultimately for every sample in the training set. These probabilities were then used to calculate various performance metrics (e.g. number of samples correctly predicted per cancer type).
Performance stats and confusion matrices as determined by cross-validation can be found at the below links: